Relationship of follicle numbers and estradiol levels to multiple implantation in 3,608 intrauterine insemination cycles
- 1 January 2001
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (1) , 69-78
- https://doi.org/10.1016/s0015-0282(00)01631-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Determinants of the outcome of intrauterine insemination: Analysis of outcomes of 9963 consecutive cyclesAmerican Journal of Obstetrics and Gynecology, 1999
- Factors responsible for multiple pregnancies after ovarian stimulation and intrauterine insemination with gonadotropinsJournal of Assisted Reproduction and Genetics, 1996
- Infertility: Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI successHuman Reproduction, 1996
- Success of intrauterine insemination using cryopreserved donor sperm is related to the age of the woman and the number of preovulatory folliclesJournal of Assisted Reproduction and Genetics, 1996
- Multiple pregnancies: risk factors and prognostic variables during induction of ovulation with human menopausal gonadotrophinsHuman Reproduction, 1991
- Relationship of follicle number, serum estradiol, and other factors to birth rate and multiparity in human menopausal gonadotropin-induced intrauterine insemination cyclesFertility and Sterility, 1991
- Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertilityFertility and Sterility, 1991
- Pregnancy rates after timed intercourse or intrauterine insemination after human menopausal gonadotropin stimulation of normal ovulatory cycles: a controlled studyFertility and Sterility, 1991
- Incidence of multiple gestations in the presence of two or more mature follicles in the conception cycle**Presented in part at the thirty-fourth annual meeting of the Pacific Coast Fertility Society, April 6 to 9, 1986, San Diego, California.Fertility and Sterility, 1987
- Diagnosis-specific serum 17β-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay**Supported in part by the Pantex Corporation, Santa Monica, California.Fertility and Sterility, 1984